E. Greenwich, CT, United States of America

Paul S Changelian

USPTO Granted Patents = 6 

Average Co-Inventor Count = 2.8

ph-index = 5

Forward Citations = 190(Granted Patents)


Location History:

  • East Greenwich, CT (US) (2005)
  • East Greenwich, RI (US) (2007)
  • E. Greenwich, CT (US) (2003 - 2009)
  • Framingham, MA (US) (2022)

Company Filing History:


Years Active: 2003-2022

Loading Chart...
6 patents (USPTO):Explore Patents

Introduction

Paul S Changelian is a prominent inventor based in E. Greenwich, Connecticut, known for his significant contributions to pharmaceutical innovations. With a total of six patents to his name, Changelian's work primarily focuses on developing novel compounds that target various diseases through innovative therapeutic strategies. His research has paved the way for new treatments that address critical health issues.

Latest Patents

Among his notable patents, Changelian has developed substituted pyrrolopyridines as JAK inhibitors. This invention relates to new pyrrolopyridine compounds with specific structures aimed at treating diseases such as pruritus, alopecia, and psoriasis, among others. The methods provided in this patent offer a new approach to inhibiting JAK kinase activity in both human and animal subjects.

Another significant patent by Changelian involves pyrrolo[2,3-d]pyrimidine compounds, which serve as inhibitors for protein tyrosine kinases, particularly Janus Kinase 3. This compound is valuable in the therapy of various autoimmune diseases and conditions, including lupus, multiple sclerosis, rheumatoid arthritis, and even cancers. His innovative approach enhances the therapeutic options available for numerous debilitating conditions.

Career Highlights

Changelian has achieved remarkable milestones throughout his career, contributing to major advancements in biotechnology and pharmaceuticals. His experience includes working with Pfizer Corporation, one of the leading pharmaceutical companies globally, where he was instrumental in advancing cutting-edge research and development initiatives.

Collaborations

Throughout his career, Paul S Changelian has collaborated with several distinguished professionals in the field, including Todd A Blumenkopf and Mark Edward Flanagan. These collaborations have strengthened his research and contributed significantly to the innovative processes leading to successful patent applications.

Conclusion

Paul S Changelian's work exemplifies dedication to scientific advancement and innovation in pharmaceuticals. With his six patents, he has made a substantial impact on treating various health conditions. As a leading inventor, Changelian continues to inspire future generations of scientists and researchers in the pursuit of novel therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…